Trial of PCC Versus FFP in Patients Undergoing Heart Surgery
Status:
Completed
Trial end date:
2020-01-29
Target enrollment:
Participant gender:
Summary
The PROPHESY trial is a single centre pilot trial investigating Fresh Frozen Plasma (FFP) or
Prothrombin Complex Concentrate (PCC) treatment for patients who are bleeding during cardiac
surgery, and who are NOT receiving a vitamin K antagonist agent (e.g. warfarin).
This pilot study will investigate the feasibility of delivering the different components of
the trial, so that investigators can determine if it's feasible to move to a future large
trial that will aim to compare the efficacy and safety of FFP versus PCC in adult patients
who are actively bleeding during cardiac surgery.